The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.

Saved in:
Bibliographic Details
Title: The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Authors: Patel NR; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Hospital, Boston, MA., Cunoosamy DM; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Fagerås M; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Taib Z; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Asimus S; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Hegelund-Myrbäck T; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Lundin S; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Pardali K; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Kurian N; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Ersdal E; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Kristensson C; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Korsback K; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Palmér R; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden., Brown MN; Innovative Medicines and Early Development, AstraZeneca, Boston, MA, USA., Greenaway S; Quintiles Drug Research Unit at Guy's Hospital, London., Siew L; Quintiles Drug Research Unit at Guy's Hospital, London., Clarke GW; Quintiles Drug Research Unit at Guy's Hospital, London.; Department of Cardiothoracic Pharmacology, NHLI, Imperial College London, London, UK., Rennard SI; Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA.; Clinical Discovery Unit, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK., Make BJ; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO., Wise RA; Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Jansson P; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2018 Mar 27; Vol. 13, pp. 1009-1019. Date of Electronic Publication: 2018 Mar 27 (Print Publication: 2018).
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29628759
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patel+NR%22">Patel NR</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.; Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cunoosamy+DM%22">Cunoosamy DM</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Fagerås+M%22">Fagerås M</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Taib+Z%22">Taib Z</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Asimus+S%22">Asimus S</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Hegelund-Myrbäck+T%22">Hegelund-Myrbäck T</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Lundin+S%22">Lundin S</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Pardali+K%22">Pardali K</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Kurian+N%22">Kurian N</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Ersdal+E%22">Ersdal E</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Kristensson+C%22">Kristensson C</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Korsback+K%22">Korsback K</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Palmér+R%22">Palmér R</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Brown+MN%22">Brown MN</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Greenaway+S%22">Greenaway S</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.<br /><searchLink fieldCode="AU" term="%22Siew+L%22">Siew L</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.<br /><searchLink fieldCode="AU" term="%22Clarke+GW%22">Clarke GW</searchLink>; Quintiles Drug Research Unit at Guy's Hospital, London.; Department of Cardiothoracic Pharmacology, NHLI, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rennard+SI%22">Rennard SI</searchLink>; Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA.; Clinical Discovery Unit, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Make+BJ%22">Make BJ</searchLink>; Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO.<br /><searchLink fieldCode="AU" term="%22Wise+RA%22">Wise RA</searchLink>; Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jansson+P%22">Jansson P</searchLink>; Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101273481%22">International journal of chronic obstructive pulmonary disease</searchLink> [Int J Chron Obstruct Pulmon Dis] 2018 Mar 27; Vol. 13, pp. 1009-1019. <i>Date of Electronic Publication: </i>2018 Mar 27 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22DOVE+Medical+Press%22">DOVE Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101273481 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1178-2005 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211769106%22">11769106 </searchLink><i>NLM ISO Abbreviation: </i>Int J Chron Obstruct Pulmon Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29628759
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/COPD.S150576
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1009
    Titles:
      – TitleFull: The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patel NR
      – PersonEntity:
          Name:
            NameFull: Cunoosamy DM
      – PersonEntity:
          Name:
            NameFull: Fagerås M
      – PersonEntity:
          Name:
            NameFull: Taib Z
      – PersonEntity:
          Name:
            NameFull: Asimus S
      – PersonEntity:
          Name:
            NameFull: Hegelund-Myrbäck T
      – PersonEntity:
          Name:
            NameFull: Lundin S
      – PersonEntity:
          Name:
            NameFull: Pardali K
      – PersonEntity:
          Name:
            NameFull: Kurian N
      – PersonEntity:
          Name:
            NameFull: Ersdal E
      – PersonEntity:
          Name:
            NameFull: Kristensson C
      – PersonEntity:
          Name:
            NameFull: Korsback K
      – PersonEntity:
          Name:
            NameFull: Palmér R
      – PersonEntity:
          Name:
            NameFull: Brown MN
      – PersonEntity:
          Name:
            NameFull: Greenaway S
      – PersonEntity:
          Name:
            NameFull: Siew L
      – PersonEntity:
          Name:
            NameFull: Clarke GW
      – PersonEntity:
          Name:
            NameFull: Rennard SI
      – PersonEntity:
          Name:
            NameFull: Make BJ
      – PersonEntity:
          Name:
            NameFull: Wise RA
      – PersonEntity:
          Name:
            NameFull: Jansson P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 03
              Text: 2018 Mar 27
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1178-2005
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: International journal of chronic obstructive pulmonary disease
              Type: main
ResultId 1